We’ve updated our Privacy Policy to make it clearer how we use your personal data.
We use cookies to provide you with a better experience. You can read our Cookie Policy here.
Drug-induced mitochondrial dysfunction has been linked to compound attrition, organ toxicity, black-box warnings, and market withdrawals, therefore it is important to identify mitochondrial toxicity during the early stages of the drug discovery process.

New in vitro strategies are being introduced to the market, which are more specific and sensitive.

Download this infographic to learn about: